UBS stuft BioNTech auf Kaufen hoch, während ein Aktienrückkaufprogramm startet. Der Fokus liegt auf der Krebsforschung.
Moderna is suing Pfizer and BioNTech for infringing patents central to Moderna's mRNA technology platform used to develop the COVID vaccine, the company said in a press release Friday. A widely ...
BioNTech (BNTX) has reached settlement agreements with the U.S. National Institutes of Health (NIH) and the University of Pennsylvania over royalties tied to its COVID-19 vaccine, resolving disputes ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. BioNTech said Thursday it would buy ...
The chapter on Pfizer and BioNTech’s mRNA patent feud with Germany’s CureVac is coming to a close, even as lawsuits over the vaccine technology continue to play out on several other fronts. Pfizer and ...
Der Biotechkonzern kommt bei der Entwicklung seiner Krebstherapien weiter voran. Dazu tragen auch die Kooperation mit dem US-Konzern Bristol Myers Squibb und die Übernahme von Curevac bei. Biontech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results